Dr. Craig Devoe, lead investigator of clinical trial at Northwell Health, answers your questions on the plasma study
Dr. Craig Devoe spoke to News 12's Elizabeth Hashagen today. Dr. Devoe is the lead investigator of a clinical trial at Northwell Health studying blood from survivors as a possible treatment for COVID-19.
•
Apr 13, 2020, 2:09 PM
•
Updated 1,718 days ago
Share:
Dr. Craig Devoe spoke to News 12's Elizabeth Hashagen today. Dr. Devoe is the lead investigator of a clinical trial at Northwell Health studying blood from survivors as a possible treatment for COVID-19.
This is what he says are the prerequisites for survivors to donate blood and possibly be a part of the study:
- You need to be without symptoms for 14 days;
- You have to have had a positive test showing that you had COVID-19.
More from News 12
1:44
Sinkhole prompts lane closures on Interstate 80 in Wharton
2:43
Multiple rain chances ahead this weekend and into next week
2:11
Boil water advisory issued for Edison Water Utility customers following water main break
1:21
Dozens of businesses impacted by major water main break in Edison
1:50
Water main break in Verona prompts boil water advisory
0:21
